Search results for "compatibility"

showing 10 items of 859 documents

Eco-scalable baicalin loaded vesicles developed by combining phospholipid with ethanol, glycerol, and propylene glycol to enhance skin permeation and…

2019

Abstract A new class of biocompatible and scalable phospholipid vesicles was developed, aiming at improving the efficacy of baicalin on the skin. Phosphatidylcholine and baicalin (a natural polyphenol) were hydrated in two steps with a mixture of ethanol, glycerol, and propylene glycol at different ratios, and a low amount of water (4%). Hence, water was almost completely replaced by the co-solvents, which were never used before as predominant dispersing medium of phospholipid vesicles. The vesicles appeared three-dimensionally structured, forming a network that conferred a high viscosity to the dispersions. The vesicles were unilamellar, small in size (∼100 nm), and stable during 12 months…

GlycerolBiocompatibilitySurface PropertiesSwineSkin AbsorptionPhospholipid02 engineering and technology01 natural scienceschemistry.chemical_compoundColloid and Surface ChemistryPhosphatidylcholine0103 physical sciencesGlycerolAnimalsPhysical and Theoretical ChemistryParticle SizePhospholipidsTransdermalSkinFlavonoidsChromatography010304 chemical physicsEthanolVesicleSurfaces and InterfacesGeneral MedicinePermeation021001 nanoscience & nanotechnologyPropylene GlycolOxidative Stresschemistry0210 nano-technologyBaicalinBiotechnologyColloids and surfaces. B, Biointerfaces
researchProduct

Supramolecular functionalization and concomitant enhancement in properties of Au25 clusters

2014

We present a versatile approach for tuning the surface functionality of an atomically precise 25 atom gold cluster using specific host-guest interactions between ?-cyclodextrin (CD) and the ligand anchored on the cluster. The supramolecular interaction between the Au25 cluster protected by 4-(t-butyl)benzyl mercaptan, labeled Au25SBB18, and CD yielding Au25SBB18�?�CDn (n = 1, 2, 3, and 4) has been probed experimentally using various spectroscopic techniques and was further analyzed by density functional theory calculations and molecular modeling. The viability of our method in modifying the properties of differently functionalized Au25 clusters is demonstrated. Besides modifying their optoe…

Gold clusterta214Molecular modelta114General EngineeringSupramolecular chemistryGeneral Physics and AstronomyCombinatorial chemistrychemistry.chemical_compoundBenzyl mercaptanchemistryComputational chemistryMolecular ProbesSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationCluster (physics)Surface modificationMoleculeGeneral Materials ScienceDensity functional theorySpectrophotometry UltravioletGoldAmerican Chemical Society; Host guest interactions; Inclusion complex; Optoelectronic properties; Quantum clusters; Spectroscopic technique; Supramolecular interactions; Surface functionalities; Biocompatibility; Cyclodextrins; Ligands; Metal ions; Supramolecular chemistry; Gold compounds; gold; article; chemistry; mass spectrometry; molecular probe; ultraviolet spectrophotometry; Gold; Molecular Probes; Spectrometry Mass Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry UltravioletACS Nano
researchProduct

Anti-HLA immunization of patients qualified for lung transplantation – Single center study

2021

For lung transplantation, the presence of donor-specific anti-HLA antibodies (DSA) is an important factor of antibody-mediated rejection (AMR) in its hyperacute, acute or chronic form during long-term follow up. The aim of the study was to assess the allosensitization of Polish patients qualified for a lung transplantation in our center. A retrospective study of 161 potential lung allograft recipients, also of 31 patients transplanted in the Uni-versity Hospital of Gdansk, between June 2018 and December 2020 were performed. 121 potential recipients were thoroughly tested for immunization status before eventual lung transplantation. SAB-testing, PRA-CDC and vPRA assessment, and HLA typing we…

Graft RejectionAnti-HLA sensitizationTransplantationHistocompatibility TestingImmunologyKidney TransplantationTransplant immunologyHLA AntigensIsoantibodiesHumansImmunology and AllergyImmunizationLung TransplantationRetrospective StudiesTransplant Immunology
researchProduct

Clinical Predictors of Immunotolerance in Heart Transplantation

2010

Abstract Background and Aim The drugs routinely administered to prevent rejection often cause lethal side effects. Tolerant patients, therefore, should be identified to minimize these problems. The aim of this analysis was to identify clinical variables that may be associated with tolerance. Methods We recruited 522 heart transplants (HT), excluding combined procedures, retransplantations, pediatric recipients, and subjects who died in the first year to obtain a cohort of 375 patients. Two groups were distinguished by the presence of echocardiographic, clinical, or pathological evidence of rejection in the first year (15 echocardiograms and 10 protocol biopsies per patient); 99 tolerant pat…

Graft RejectionHeart transplantationTransplantationmedicine.medical_specialtyUnivariate analysisMultivariate analysisbusiness.industrymedicine.medical_treatmentSurgeryMajor Histocompatibility ComplexTransplantationElectrocardiographyText miningInternal medicineCohortImmune TolerancemedicineHeart TransplantationHumansSurgerybusinessPathologicalSurvival analysisTransplantation Proceedings
researchProduct

14th International HLA and Immunogenetics Workshop: Report on the Prospective Chronic Rejection Project

2007

An international collaborative study of 45 transplant centers was undertaken at the 14th International HLA (human leukocyte antigen) and Immunogenetics Workshop to see if HLA antibodies detected posttransplant are predictive of chronic graft failure. With the newly developed assay, MICA (major histocompatibility complex class I-related chain A) antibodies were also measured and their effect analyzed. Total of 5219 sera from patients who were more than 6 months posttransplant with functioning graft were tested for HLA antibodies by enzyme-linked immunosorbent assay, flow cytometry, or Luminex. HLA antibodies were found in 27.2% of kidney patients, 23.6% in the liver, 52.7% in the heart, and …

Graft RejectionMICA antibodyImmunologyHuman leukocyte antigenHistocompatibility TestingImmunogeneticsMajor histocompatibility complexBiochemistryimmunogenetics workshopchronic rejectionHLA AntigensTransplantation ImmunologyImmunogeneticsGeneticsmedicineHumansImmunology and AllergyHLA antibodyKidneyLungbiologybusiness.industryHistocompatibility TestingGraft SurvivalHistocompatibility Antigens Class IPanel reactive antibodymulti-center studyGeneral MedicineKidney Transplantationmedicine.anatomical_structureChronic DiseaseImmunologybiology.proteinHeart TransplantationAntibodybusinessTissue Antigens
researchProduct

Induction and tolerization of anti-male CD8+ cytotoxic T lymphocytes by in vivo immunization with an H-Y-derived peptide

1999

Abstract We have analyzed the immune response induced by a 9mer synthetic peptide derived from the male histocompatibility antigen H-Y and containing D b -binding motifs in C57BL/6 mice. In this study we report that a single, subcutaneous injection of the peptide emulsified in IFA gave rise to the development of male-specific CD8 + T cells which displayed H-Y-specific proliferative response in vitro and showed a Tc1-type pattern of cytokine production (i.e. they secreted IFN-γ and IL-2, but not IL-4 and IL-10). Development of a strong cytotoxic activity required in vitro stimulation with specific peptide and IL-2: under these culture conditions, we were able to generate potent CD8 + CTLs th…

Graft RejectionMaleTime Factorsmedicine.medical_treatmentH-Y AntigenImmunologyPeptideBiologyMajor histocompatibility complexMiceImmune systemAntigenOsmotic PressuremedicineAnimalsImmunology and AllergyCytotoxic T cellH-Y antigenchemistry.chemical_classificationSkin TransplantationGeneral MedicineMolecular biologyMice Inbred C57BLCytokineSolubilitychemistryImmunologybiology.proteinFemalePeptidesCD8T-Lymphocytes CytotoxicHuman Immunology
researchProduct

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

2020

International audience; Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major histocompatibility complex (MHC) class I-binding epitopes in the tail length tape measure protein (TMP) of a prophage found in the genome of the bacteriophage Enterococcus hirae Mice bearing E. hirae harboring this prophage mounted a TMP-specific H-2Kb-restricted CD8+ T lymphocyte response upon immunotherapy with cyclophosphamide or anti-PD-1 antibodies. Administration of bacterial strains engineered to express the TMP epitope improved immunotherapy in mice. In renal and lung cancer patients, the presence of the ent…

H-2 AntigenProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesEpitopeEpitopesFecesMice0302 clinical medicineEnterococcus hiraeNeoplasmsMonoclonalBacteriophages0303 health sciencesMultidisciplinarybiologyAntibodies MonoclonalViral Tail ProteinsAlkylating3. Good healthmedicine.anatomical_structure030220 oncology & carcinogenesisCross ReactionEpitopeImmunotherapyHumanT cellAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/CancerCross ReactionsMajor histocompatibility complexAntibodiesMicrobiology03 medical and health sciencesAnimals; Antibodies Monoclonal; Antigens Neoplasm; Antineoplastic Agents Alkylating; Bacteriophages; CD8-Positive T-Lymphocytes; Cross Reactions; Cyclophosphamide; Enterococcus hirae; Epitopes; Feces; Gastrointestinal Microbiome; H-2 Antigens; Histocompatibility Antigens Class I; Humans; Immunotherapy; Mice; Neoplasms; Programmed Cell Death 1 Receptor; Viral Tail Proteins[SDV.CAN] Life Sciences [q-bio]/CancerAntigenAntigens NeoplasmMHC class ImedicineAnimalsHumansAntigensBacteriophageAntineoplastic Agents AlkylatingCyclophosphamideProphage030304 developmental biologyEnterococcus hiraeAnimalHistocompatibility Antigens Class IH-2 AntigensCD8-Positive T-Lymphocytebiology.organism_classificationGastrointestinal Microbiomebiology.proteinNeoplasmFeceCD8
researchProduct

The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.

2003

HLA-G as a non-classical MHC class I molecule exhibits a limited tissue distribution and exerts multiple immune regulatory functions including the induction of immune tolerance. In addition, HLA-G has been detected in some tumors of different histology and therefore may represent a novel immune escape mechanism of tumor cells. Despite the immunogenicity of renal cell carcinoma (RCC), outgrowth of tumor cells occurs which might be attributable to abrogation of efficient anti-tumor responses. We here review the potential role of HLA-G in RCC immunology, the HLA-G expression pattern and its functional consequences on immune responses. A heterogenous constitutive and interferon- inducible HLA-G…

HLA-G AntigensCancer ResearchLymphokine-activated killer cellT cellmedicine.medical_treatmentHistocompatibility Antigens Class IHuman leukocyte antigenImmunotherapyBiologyFlow CytometryKidney NeoplasmsImmune toleranceImmunosurveillanceInterferon-gammamedicine.anatomical_structureImmune systemHLA AntigensHLA-GImmunologymedicineCancer researchHumansImmunotherapyRNA MessengerCarcinoma Renal CellSeminars in cancer biology
researchProduct

HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

2003

Non-classical MHC class Ib molecules have attracted growing interest in recent years, especially because they interact with non-T-cell inhibitory or triggering receptors expressed on natural killer (NK) and T cells, suggesting that they have a role in immune recognition. Abnormalities in MHC class Ib expression are frequently found in human tumors of various histologies and might be associated with poor clinical outcome despite the local accumulation of immune competent cells. Available data suggest that the balance between activating and suppressing signals significantly influences the efficacy of the immune response and consequently of tumor progression.

HLA-G AntigensMaleAntitumor immunitybiologyImmunologyHistocompatibility Antigens Class IGene ExpressionGenes MHC Class Ichemical and pharmacologic phenomenaInhibitory postsynaptic potentialAcquired immune systemImmune systemTumor progressionHLA AntigensHLA-GNeoplasmsMHC class IImmunologybiology.proteinImmunology and AllergyHumansFemaleReceptorTrends in immunology
researchProduct

AMCAS: Advanced Methods for the Co-Design of Complex Adaptive Systems

2006

Abstract This work proposes a new approximation to design and program Complex Adaptive Systems (CAS), these systems comprise neural network, intelligent agents, genetic algorithms, support vector machines and artificial intelligence systems in general. Due to the complexity of such systems, it is necessary to build a design environment able to ease the design work, allowing reusability and easy migration to hardware and/or software. Ptolemy II is used as the base system to simulate and evaluate the designs with different Models of Computation so that an optimum decision about the hardware or software implementation platform can be taken.

Hardware architectureSystem of systemsComputer sciencebusiness.industryModel of computationDistributed computingcomputer.software_genreIntelligent agentSoftwareComputer engineeringSystems development life cycleSystems designHardware compatibility listbusinesscomputerReusability
researchProduct